The abstract is read at the publisher; the summary is JClub's.
Sodium channel alpha subunit proteins are the top-ranked targets for carbamazepine, lamotrigine, eslicarbazepine, licarbazepine, lacosamide, and phenytoin, with cenobamate ranking second to GABA-A receptor.
- Why it matters: Different efficacy and side-effect spectra among sodium channel blockers may reflect poorly mapped off-target interactions, protein binding, and subunit selectivity.
- What they did: A neural network computational pipeline used DRIFT for proteome-wide target prediction, Reactome pathway mapping, and molecular docking to model drug–target atomistic interactions. Predicted target counts ranged from 59 each for eslicarbazepine and licarbazepine to 18 for lacosamide.
- The result: Pathways repeatedly enriched rapid depolarisation and L1–ankyrin interaction across all drugs, with predicted off-targets including cannabinoid CB1 receptor for phenytoin and carbonic anhydrases for lacosamide; docking binding scores ranged from -24 to -31 kcal/mol.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.